Details for Patent: 10,251,900
✉ Email this page to a colleague
Which drugs does patent 10,251,900 protect, and when does it expire?
Patent 10,251,900 protects ARIKAYCE KIT and is included in one NDA.
This patent has forty-four patent family members in twenty-one countries.
Summary for Patent: 10,251,900
| Title: | Methods for treating pulmonary non-tuberculous mycobacterial infections |
| Abstract: | Provided herein are methods for treating a pulmonary infection in a patient in need thereof, for example, a nontuberculous mycobacterial pulmonary infection for at least one treatment cycle. The method comprises administering to the lungs of the patient a pharmaceutical composition comprising a liposomal complexed aminoglycoside comprising a lipid component comprising electrically neutral lipids and an aminoglycoside. Administration comprises aerosolizing the pharmaceutical composition to provide an aerosolized pharmaceutical composition comprising a mixture of free aminoglycoside and liposomal complexed aminoglycoside, and administering the aerosolized pharmaceutical composition via a nebulizer to the lungs of the patient. The methods provided herein result in a change from baseline on the semi-quantitative scale for mycobacterial culture for a treated patient, and/or NTM culture conversion to negative during or after the administration period. |
| Inventor(s): | Eagle; Gina (Morristown, NJ), Gupta; Renu (Moorestown, NJ) |
| Assignee: | INSMED INCORPORATED (Bridgewater, NJ) |
| Application Number: | 16/007,075 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Device; Dosage form; |
Drugs Protected by US Patent 10,251,900
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Insmed Inc | ARIKAYCE KIT | amikacin sulfate | SUSPENSION, LIPOSOMAL;INHALATION | 207356-001 | Sep 28, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATING MYCOBACTERIUM AVIUM COMPLEX (MAC) LUNG DISEASE IN ADULTS AS PART OF A COMBINATION DRUG REGIMEN | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,251,900
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2015258947 | ⤷ Try a Trial | |||
| Australia | 2020204530 | ⤷ Try a Trial | |||
| Brazil | 112016026699 | ⤷ Try a Trial | |||
| Canada | 2949078 | ⤷ Try a Trial | |||
| China | 106535877 | ⤷ Try a Trial | |||
| Cyprus | 1123411 | ⤷ Try a Trial | |||
| Denmark | 3142643 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
